|ResMed Inc -- USA Stock|| |
USD 88.51 0.28 0.32%
President ? Respiratory Care
Mr. Richard McHale is President Respiratory Care of the Company. He previously served as the companys chief human resources officer, beginning in November 2013, and joined ResMed in 2011 as director of its United Kingdom business team. Mr. McHale has 25 years experience in the life sciences sector, working primarily in commercial roles within pharmaceutical, biotechnology and medical technology companies. Prior to joining ResMed, he was managing director of UCB Pharmas United Kingdom and Ireland business units. He also served as chair of the European Medicines Group and a member of the Board of Management for the Association of British Pharmaceutical Industry
Age: 52 President Since 2017
858 836-5000 www.resmed.com
McHale holds a master?s degree in coaching psychology from the Metanoia Institute in London.
The company has Return on Asset of 8.72 %
which means that on every $100 spent on asset it made $8.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 18.43 %
implying that it generated $18.43 on every 100 dollars invested.
The company has 1.02 B in debt with debt to equity (D/E) ratio of 49.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed Inc has Current Ratio of 4.63 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloudbased software applications that diagnose, treat, and manage respiratory disorders. ResMed Inc (RMD) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 5,250 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.